IT HAS BEEN SHOWN that mammalian cells in culture can be transformed to a malignant phenotype by treatment with carcinogenic agents. Such in vitro transformation assays have been extremely useful, both for the testing of potential carcinogens and for the elucidation of cellular mechanisms of oncogenesis (DiPaolo, 1974; Heidelberger, 1973) . Differing endpoints have been used as the criteria for transformation. These include changes in morphology (DiPaolo et al., 1969; Reznikoff et al., 1973) and the loss of anchorage dependence for growth (Bouck & DiMayorca, 1976; Styles, 1977) . Ultimately, however, the validity of any such in vitro system can only be justified by demonstrating a direct correspondence with the behaviour of the same cells in vivo. In other words, what are regarded as normal cells must not be tumorigenic in an appropriate host animal, whilst cells that are judged to be transformed in vitro must be (Shields, 1976) . Until in vitro transformation can be compared to in vivo tumorigenesis in terms of molecular mechanism, this would probably remain as the most operational criterion.
The C3H mouse embryo-derived 1OT2 cell line has been one of the most widely used in vitro transformation systems. We have shown that exposure of these cells to 254 nm ultraviolet light (UV) alone will induce both transformed cells and ouabain-resistant mutants, thus providing a single system in which mutagenesis and transformation can be studied in parallel (Chan & Little, 1976 , 1978 . In this communication, we report that scoring UVinduced transformants in this system by a morphological criterion indeed correlates closely with both the acquisition of anchorage independence for growth in vitro and tumorigenicity in vivo.
The methodology for inducing transformants by 254 nm UV has been described elsewhere (Chan & Little, 1976) . Cells from transformed foci were cloned by the steelcylinder method and grown up into sufficient quantities for the experiments. The normal 1 OT I cells used as controls were cells that have never been exposed to UV; they were in Passages 14-16.
To test for anchorage independence for growth, melted agar (1-2%) containing 0.4% bacto-peptone was mixed at 450C
with an equal volume of Eagle's basal medium made to twice the normal concentration and supplemented with 20% heat-inactivated foetal calf serum (Flow Laboratories). Aliquots of 4 ml of this mixture were deposited on 60 mm plastic tissue-culture dishes (Falcon) as the base layer and cooled to room temperature. Separate 4ml aliquots of the same mixture were mixed with equal volumes of a test cell suspension prepared to a concentration of 5 x 104 cell/ml in normal medium (i.e., the concentration with 10% serum). This mixed cell suspension, now containing 2-5x 104 cell/ml, 0.3% agar and 0-1% bacto-peptone, was then plated in 4 ml aliquots on top of the base layer. The plates were incubated for 2 weeks in a 5% C02 humidified incubator held at 37°C and then examined both macroscopically and microscopically for colony formation.
To test for tumorigenicity, an appropriate number of test cells suspended in 1 ml of Earle's balanced salt solution were injected s.c. at the nape of the neck into C3H/HENMTV-mice obtained from the Frederick Cancer Research Center, Frederick, Maryland, U.S.A. These mice were syngeneic with the animals from which the 10TI cell line was originally derived.
The protocol of the transformation experiments allows cells that have lost the property of contact inhibition of growth to produce dense foci of piled-up cells on top of a background monolayer. From several experiments, we randomly selected 8 independent foci for cloning. All 8 foci showed extreme piling-up of cells, classified as Type II or Type III according to the original classification proposed by Reznikoff et al. (1973) . The criss-crossing cell morphology is seen only at the periphery of Type III foci. These criss-cross cells, usually smaller than normal cells, give a Type III focus a diffused edge, whereas the interface between a Type II focus and the background monolayer is abrupt. The Figure shows were injected, there was a 100% tumour take. The tumours became discernible by palpation about one month after injection. By 3 months, they had either killed the host or caused gross deformity of the neck region. When inocula of less than 2 x 106 Type III cells were injected, the tumour yield was less than 100%. This agrees with the results of the coinjection experiments of Stiles et al. (1976) in that the number of cells in the inoculum must be large enough to provide a local microenvironment that is suitable for the growth of the transformed cells. The one line derived from a Type II focus failed to cause tumours even at inocula of 2 x106 cells, consistent with the failure of Type II cells to grow in soft agar (Table I) . Likewise, no tumours arose in animals injected with normal cells. There is therefore good agreement between the 3 endpoints, morphological change, growth without anchorage and tumorigenicity. On the basis of these results, we conclude that the Type III foci induced by UV in 1OTI cells are indeed malignant transformants. These data also show that Type II cells, though having lost the property of contact inhibition of growth, have not acquired full malignant potential as shown by criss-cross morphology and the abilities to grow without anchorage and to form tumours in the host. These results suggest that the transformation of a normal cell to a fully malignant one is a multi-step process with the loss of contact inhibition of growth being an earlier step than morphological change, anchorage independence and tumorigenicity. It is not clear, however, whether the acquisition of these transformed traits follows a mechanistically defined sequence or not, since we have not been able to isolate clones according to an endpoint other than morphology, and test for their behaviour with respect to the other characters. Barrett et al. (1977) , working with hamster embryo cells treated with benzo-(a)pyrene, seem to favour the view of a defined order of acquisition of the transformed traits. In any event, it seems clear that cells which have been initiated in the transformation process can be arrested at points bWfore the process is complete. This might be the basis for demarcating the oncogenic process into the 2 phases of initiation and promotion (Berenblum, 1975; Sivak, 1978) .
Finally we propose that, in using the 1OT' system as a quantitative assay for transformation by UV, only Type III foci should be scored as transformants.
